Yeah.....
What does an investor pay for a fin tech thats reached it's used by date on growth? 20 times EBIT? Certainly not 200 times EBIT....
let alone any adverse regulatory findings.
- Forums
- ASX - By Stock
- SP1
- something different to talk about
something different to talk about, page-5
-
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)